secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76231 grounded facts newest August 28, 2026, 4:49 PM ET RSS · JSON

Showing 2451–2500 of 18616

Departed

Andrew Spaventa

Chief Executive Officer and Chair of the Board
Singular Genomics Systems, Inc.
Effective
2025-02-21
Successor
Joshua Stahl
Filed
February 27, 2025, 6:59 PM ET
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Departed

Dalen Meeter

Chief Financial Officer
Singular Genomics Systems, Inc.
Effective
2025-02-21
Filed
February 27, 2025, 6:59 PM ET
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Appointed

Joshua Stahl

Chief Executive Officer
Singular Genomics Systems, Inc.
Effective
2025-02-21
Filed
February 27, 2025, 6:59 PM ET
Immediately following the Effective Time, Joshua Stahl was appointed as the Company’s Chief Executive Officer and Jason Myers was appointed as the Company’s President.
Departed

Claire Spofford

Chief Executive Officer and President
JILL · J.Jill, Inc.
Effective
2025-04-30
Successor
Mary Ellen Coyne
Filed
February 27, 2025, 6:59 PM ET
Ms. Spofford has agreed to extend her retirement date to April 30, 2025
Appointed

Mary Ellen Coyne

Chief Executive Officer and President
JILL · J.Jill, Inc.
Effective
2025-05-01
Filed
February 27, 2025, 6:59 PM ET
On February 27, 2025, J.Jill, Inc. (the “Company”) announced that it has appointed Mary Ellen Coyne to serve as the Company’s Chief Executive Officer and President to succeed the Company’s current Chief Executive Officer and President, Claire Spofford, following Ms. Spofford’s previously disclosed decision to retire.
Appointed

Don Kim

Chief Financial Officer
CNTN · Canton Strategic Holdings, Inc.
Effective
2025-03-27
Filed
February 27, 2025, 6:59 PM ET
appointed Don Kim as Chief Financial Officer of the Company, effective as of March 27, 2025.
Departed

Thomas Hess

Chief Financial Officer
CNTN · Canton Strategic Holdings, Inc.
Effective
2025-03-26
Successor
Don Kim
Filed
February 27, 2025, 6:59 PM ET
accepted the resignation of Thomas Hess as Chief Financial Officer of the Company, effective as of March 26, 2025.
Departed

Michael D. Cahill

President and Chief Executive Officer
VWFB · VWF Bancorp, Inc.
Effective
2025-12-31
Filed
February 27, 2025, 6:59 PM ET
On February 24, 2025, Michael D. Cahill, VWF Bancorp Inc.'s (the "Company") President and Chief Executive Officer, a member of the Board of Directors of the Company, the Company's subsidiary GreenWay Bank's (the "Bank") President and Chief Executive Officer, and a member of the Board of Directors of the Bank, notified the Company and the Bank that he will retire from the Company and the Bank, at the end of the current term of his employment agreement, effective December 31, 2025.
Departed

Steven Tuch

Executive Vice President and Chief Financial Officer
VTVT · vTv Therapeutics Inc.
Effective
2025-03-21
Filed
February 27, 2025, 6:59 PM ET
On February 24, 2025, Steven Tuch, Executive Vice President and Chief Financial Officer of vTv Therapeutics Inc. (the "Company"), informed the Company of his intention to resign from his position effective March 21, 2025.
Appointed

Navam Welihinda

Chief Financial Officer
ESTC · Elastic N.V.
Effective
2025-02-28
Filed
February 27, 2025, 6:59 PM ET
On February 25, 2025, the Company’s Board of Directors appointed Navam Welihinda as Elastic’s Chief Financial Officer, effective as of February 28, 2025, to succeed Eric Prengel.
Departed (interim)

Eric Prengel

Interim Chief Financial Officer
ESTC · Elastic N.V.
Effective
2025-02-28
Successor
Navam Welihinda
Filed
February 27, 2025, 6:59 PM ET
Eric Prengel, who has served as the Interim Chief Financial Officer of the Company since December 14, 2024, will cease to serve in this role on February 28, 2025 upon the effectiveness on that date of the appointment of Navam Welihinda as the Company’s Chief Financial Officer
Appointed

Samuel Knipper

Chief Financial Officer
Innovation1 Biotech Inc.
Effective
2025-02-23
Filed
February 27, 2025, 6:59 PM ET
On February 23, 2025, Innovation1 Biotech Inc. (the “Company”) appointed Samuel Knipper to serve as chief financial officer of the Company.
Role change (interim)

David Lazar

Interim Chief Executive Officer
BGMS · Bio Green Med Solution, Inc.
Effective
2025-02-26
Successor
Datuk Dr. Doris Wong Sing Ee
Filed
February 27, 2025, 6:59 PM ET
David Lazar, the Company’s interim Chief Executive Officer, interim principal financial officer, interim principal accounting officer, and Secretary, provided notice of his resignation as Chief Executive Officer and Secretary of the Company effective February 26, 2025.
Appointed

Datuk Dr. Doris Wong Sing Ee

Chief Executive Officer
BGMS · Bio Green Med Solution, Inc.
Effective
2025-02-26
Filed
February 27, 2025, 6:59 PM ET
the Board appointed Datuk Dr. Doris Wong Sing Ee, as Chief Executive Officer and, in such role, she will serve as the Company’s principal executive officer.
Appointed

Paul M. Shoukry

Chief Executive Officer
RJF · RAYMOND JAMES FINANCIAL INC
Effective
2025-02-20
Filed
February 26, 2025, 6:59 PM ET
Paul M. Shoukry simultaneously assumed the role of CEO
Appointed

Niccolo de Masi

President and Chief Executive Officer
IONQ · IonQ, Inc.
Effective
2025-02-26
Filed
February 26, 2025, 6:59 PM ET
the Board appointed Niccolo de Masi to serve as President and Chief Executive Officer of the Company, succeeding Peter Chapman effective as of February 26, 2025
Appointed

Stephen C. Farrell

President and Chief Executive Officer
STAA · STAAR SURGICAL CO
Effective
2025-02-26
Filed
February 26, 2025, 6:59 PM ET
the Board appointed Stephen C. Farrell to succeed Thomas G. Frinzi as President and Chief Executive Officer, effective February 26, 2025
Departed

Thomas G. Frinzi

President and Chief Executive Officer
STAA · STAAR SURGICAL CO
Effective
2025-02-26
Successor
Stephen C. Farrell
Filed
February 26, 2025, 6:59 PM ET
Effective as the Effective Date, Mr. Frinzi has agreed to step down at the request of the Board from his positions as President and Chief Executive Officer, and he will cease to serve as a member of the Board of Directors and Board Chair and all other positions with the Company and its subsidiaries.
Departed

Madhu Ranganathan

Chief Financial Officer
OTEX · OPEN TEXT CORP
Effective
2025-03-05
Successor
Chadwick Westlake
Filed
February 26, 2025, 6:59 PM ET
to succeed Madhu Ranganathan.
Appointed

Chadwick Westlake

Executive Vice President, Chief Financial Officer
OTEX · OPEN TEXT CORP
Effective
2025-03-05
Filed
February 26, 2025, 6:59 PM ET
appointment of Chadwick Westlake as Executive Vice President, Chief Financial Officer, effective March 5, 2025, to succeed Madhu Ranganathan.
Departed

Stephen Yarad

Chief Financial Officer
ALTI · AlTi Global, Inc.
Effective
2025-02-26
Successor
Michael W. Harrington
Filed
February 26, 2025, 6:59 PM ET
On February 26, 2025, AlTi Global, Inc. (the “Company”) announced the appointment of Michael W. Harrington as the Company’s Chief Financial Officer and the departure of Stephen Yarad as Chief Financial Officer of the Company.
Appointed

Michael W. Harrington

Chief Financial Officer
ALTI · AlTi Global, Inc.
Effective
2025-02-26
Filed
February 26, 2025, 6:59 PM ET
On February 26, 2025, AlTi Global, Inc. (the “Company”) announced the appointment of Michael W. Harrington as the Company’s Chief Financial Officer and the departure of Stephen Yarad as Chief Financial Officer of the Company.
Departed

Matthew L. Trerotola

Chief Executive Officer
ENOV · Enovis CORP
Filed
February 26, 2025, 6:59 PM ET
On February 25, 2025, Matthew L. Trerotola notified the Board of Directors (the “Board”) of Enovis Corporation (the “Company”) of his intention to retire from his current position as Chief Executive Officer (“CEO”) of the Company, effective upon his successor being appointed by the Board and assuming the position as CEO of the Company.
Departed

Niccolo de Masi

Chief Executive Officer
dMY Squared Technology Group, Inc.
Effective
2025-02-26
Successor
Harry L. You
Filed
February 26, 2025, 6:59 PM ET
On February 26, 2025, Niccolo de Masi, an officer and a member of the Board of Directors (the “Board”) of dMY Squared Technology Group, Inc. (the “Company”), notified the Company of his decision to resign as Chief Executive Officer of the Company and as a member of the Board, effective immediately, in order to pursue another opportunity.
Role change

Harry L. You

Chief Executive Officer
dMY Squared Technology Group, Inc.
Effective
2025-02-26
Filed
February 26, 2025, 6:59 PM ET
Effective February 26, 2025, Harry L. You, the Company’s Chief Financial Officer and Chairman, was appointed as Chief Executive Officer of the Company.
Departed

Ying Cao

chief financial officer
SGLY · Singularity Future Technology Ltd.
Effective
2025-02-20
Successor
Chee Jiong Ng
Filed
February 26, 2025, 6:59 PM ET
On February 20, 2025, Mr. Ying Cao resigned from his position as the chief financial officer (“ CFO ”) of Singularity Future Technology Ltd. (the “ Company ”).
Appointed

Chee Jiong Ng

chief financial officer
SGLY · Singularity Future Technology Ltd.
Effective
2025-02-21
Filed
February 26, 2025, 6:59 PM ET
On February 21, 2025, the board of directors of the Company (the “ Board ”) appointed Mr. Chee Jiong Ng as the CFO of the Company to fill the vacancy resulting from Mr. Ying Cao’s resignation.
Appointed (interim)

Michael (Mike) Milotich

Interim Chief Executive Officer
MQ · Marqeta, Inc.
Effective
2025-02-26
Filed
February 26, 2025, 6:59 PM ET
the Board of Directors (the “Board”) has appointed Michael (Mike) Milotich as Interim Chief Executive Officer (principal executive officer), effective immediately.
Departed

Simon Khalaf

Chief Executive Officer and Director
MQ · Marqeta, Inc.
Effective
2025-02-24
Successor
Michael (Mike) Milotich
Filed
February 26, 2025, 6:59 PM ET
Simon Khalaf, who has stepped down as Chief Executive Officer and as a director as of February 24, 2025.
Appointed

Louis-Jacques Tanguy

Executive Vice President and Chief Financial Officer
ATH-PA · Athene Holding Ltd.
Effective
2025-03-01
Filed
February 26, 2025, 6:59 PM ET
On February 26, 2025, Athene Holding Ltd. (the “Company”) announced that Louis-Jacques Tanguy had been appointed Executive Vice President and Chief Financial Officer of the Company, with such appointment to be effective as of March 1, 2025.
Role change

Martin P. Klein

Executive Vice President and Chief Financial Officer
ATH-PA · Athene Holding Ltd.
Effective
2025-03-01
Successor
Louis-Jacques Tanguy
Filed
February 26, 2025, 6:59 PM ET
Effective upon Mr. Tanguy’s appointment as described above, Mr. Klein retired from his position as Executive Vice President and Chief Financial Officer of the Company and assumed the role of Senior Advisor with the Company.
Appointed

William Wagner

Chief Executive Officer
SEMrush Holdings, Inc.
Effective
2025-03-10
Filed
February 26, 2025, 6:59 PM ET
On February 22, 2025, William Wagner, age 57, was appointed by the Board as the CEO, effective as of the Transition Date.
Departed

Michael P. Scarpelli

Chief Financial Officer
SNOW · Snowflake Inc.
Filed
February 26, 2025, 6:59 PM ET
On February 25, 2025, Michael P. Scarpelli notified Snowflake Inc. (the “ Company ”) of his intention to retire as the Company’s Chief Financial Officer.
Departed

Kenneth Cornick

Chief Financial Officer
YOU · Clear Secure, Inc.
Effective
2025-03-31
Successor
Jennifer Hsu
Filed
February 26, 2025, 6:59 PM ET
he will continue to serve as Chief Financial Officer until the commencement of his successor’s employment
Appointed

Jennifer Hsu

Chief Financial Officer
YOU · Clear Secure, Inc.
Effective
2025-03-31
Filed
February 26, 2025, 6:59 PM ET
Jennifer Hsu as Chief Financial Officer of the Company, effective March 31, 2025
Departed

Marcy D. Mutch

Chief Financial Officer
FIBK · FIRST INTERSTATE BANCSYSTEM INC
Effective
2025-05-31
Successor
David P. Della Camera
Filed
February 25, 2025, 6:59 PM ET
On February 20, 2025, Marcy D. Mutch notified First Interstate BancSystem, Inc. (the “Company”) of her intention to retire as a full-time employee at the end of 2025 and to step down after a transition period as the Company’s Executive Vice President and Chief Financial Officer (“CFO”) effective May 31, 2025 (the “Retirement”).
Appointed

David P. Della Camera

Chief Financial Officer
FIBK · FIRST INTERSTATE BANCSYSTEM INC
Filed
February 25, 2025, 6:59 PM ET
her announced successor, the Company’s current Deputy Chief Financial Officer, David P. Della Camera.
Appointed

Lindsay Androski

Chief Executive Officer
ABUS · Arbutus Biopharma Corp
Effective
2025-02-24
Filed
February 25, 2025, 6:59 PM ET
Ms. Androski, as Chief Executive Officer of the Company, will not receive compensation for her service as a director.
Role change

Jamie Miller

Chief Financial and Operating Officer
PYPL · PayPal Holdings, Inc.
Effective
2025-02-25
Filed
February 25, 2025, 6:59 PM ET
Jamie Miller, the Company’s Executive Vice President, Chief Financial Officer, has been appointed to the expanded role of Chief Financial and Operating Officer
Appointed

Sabrina Simmons

Chief Financial Officer
WOOF · Petco Health & Wellness Company, Inc.
Effective
2025-02-17
Filed
February 25, 2025, 6:59 PM ET
Sabrina Simmons succeeded Brian LaRose as the Company’s Chief Financial Officer (the “CFO Succession”), effective as of February 17, 2025
Departed

Brian LaRose

Chief Financial Officer
WOOF · Petco Health & Wellness Company, Inc.
Effective
2025-02-17
Successor
Sabrina Simmons
Filed
February 25, 2025, 6:59 PM ET
Sabrina Simmons succeeded Brian LaRose as the Company’s Chief Financial Officer (the “CFO Succession”), effective as of February 17, 2025
Departed

Aaron Sullivan

Executive Vice President, Chief Financial Officer, Treasurer and Secretary
LVO · LiveOne, Inc.
Effective
2025-02-19
Successor
Ryan Carhart
Filed
February 25, 2025, 6:59 PM ET
who notified the Company on the Effective Date that he is leaving the Company to pursue another professional opportunity effective as of the Effective Date.
Role change

Ryan Carhart

Chief Financial Officer, Treasurer and Secretary
LVO · LiveOne, Inc.
Effective
2025-02-19
Filed
February 25, 2025, 6:59 PM ET
Effective as of February 19, 2025 (the “Effective Date”), LiveOne, Inc. (the “Company”) appointed Ryan Carhart, the Company’s current Vice President and Controller, as the Company’s Chief Financial Officer, Treasurer and Secretary, to succeed Aaron Sullivan
Departed

Aaron Sullivan

Executive Vice President, Chief Financial Officer, Treasurer and Secretary
PODC · PodcastOne, Inc.
Effective
2025-02-19
Successor
Ryan Carhart
Filed
February 25, 2025, 6:59 PM ET
Mr. Sullivan’s departure was not as a result of any dispute with the Company.
Appointed

Ryan Carhart

Chief Financial Officer
PODC · PodcastOne, Inc.
Effective
2025-02-19
Filed
February 25, 2025, 6:59 PM ET
Effective as of February 19, 2025 (the “Effective Date”), PodcastOne, Inc. (the “Company”) appointed Ryan Carhart, the Company’s current Vice President and Controller, as the Company’s Chief Financial Officer, Treasurer and Secretary, to succeed Aaron Sullivan
Departed

Robert Mattacchione

Chief Executive Officer
Novo Integrated Sciences, Inc.
Effective
2025-03-07
Filed
February 25, 2025, 6:59 PM ET
on February 20, 2025, the Company and Mr. Mattacchione agreed to extend the effective date of Mr. Mattacchione’s resignation to no later than March 7, 2025, in order to provide the Company the necessary time to complete an efficient transition of the Chief Executive Officer position.
Departed

Brian Hahn

Chief Financial Officer
CBIO · CRESCENT BIOPHARMA, INC.
Effective
2025-02-21
Filed
February 25, 2025, 6:59 PM ET
each of Mr. Harout Semerjian, the Chief Executive Officer of the Company and Mr. Brian Hahn, the Company’s Chief Financial Officer, ceased his respective employment with the Company as of February 21, 2025
Departed

Harout Semerjian

Chief Executive Officer
CBIO · CRESCENT BIOPHARMA, INC.
Effective
2025-02-21
Filed
February 25, 2025, 6:59 PM ET
each of Mr. Harout Semerjian, the Chief Executive Officer of the Company and Mr. Brian Hahn, the Company’s Chief Financial Officer, ceased his respective employment with the Company as of February 21, 2025
Departed (interim)

Peter Rawlinson

Chief Executive Officer and Chief Technology Officer
LCID · Lucid Group, Inc.
Effective
2025-02-21
Successor
Marc Winterhoff
Filed
February 25, 2025, 6:59 PM ET
On February 25, 2025, Lucid Group, Inc. (“ Lucid ” or the “ Company ”) announced that Peter Rawlinson, the Company’s Chief Executive Officer (“ CEO ”) and Chief Technology Officer, resigned from his positions and the Company’s board of directors (the “ Board ”) on February 21, 2025 (the “ Effective Date ”).
Appointed (interim)

Marc Winterhoff

Interim Chief Executive Officer
LCID · Lucid Group, Inc.
Effective
2025-02-21
Filed
February 25, 2025, 6:59 PM ET
On the Effective Date, in connection with Mr. Rawlinson’s departure, the Board appointed Marc Winterhoff, the current Chief Operating Officer (“ COO ”) of the Company, as Interim CEO, effective immediately.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.